Yanyang Wang

Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.

Cancer stem cell marker Bmi-1 expression is associated with basal-like phenotype and poor survival in breast cancer.

Preclinical evidences toward the use of triterpenoid CDDO-Me for solid cancer prevention and treatment.

VMAT planning study in rectal cancer patients.

Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.

Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells.

The emerging role of CaMKII in cancer.

Therapeutic effects of C-28 methyl ester of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO-Me; bardoxolone methyl) on radiation-induced lung inflammation and fibrosis in mice.

Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy.

AT-101 enhances gefitinib sensitivity in non-small cell lung cancer with EGFR T790M mutations.

Hippocampal-Sparing Whole-Brain Radiotherapy for Lung Cancer.

Combining Carcinoembryonic Antigen and Platelet to Lymphocyte Ratio to Predict Brain Metastasis of Resected Lung Adenocarcinoma Patients.

Combing NLR, V20 and mean lung dose to predict radiation induced lung injury in patients with lung cancer treated with intensity modulated radiation therapy and chemotherapy.

FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β-catenin through mRNA demethylation.

Nrf2-Mediated Metabolic Reprogramming in Cancer.

NOX4 expression and distal arteriolar remodeling correlate with pulmonary hypertension in COPD.

Thalidomide (THD) alleviates radiation induced lung fibrosis (RILF) via down-regulation of TGF-β/Smad3 signaling pathway in an Nrf2-dependent manner.

Prognostic Value of Combined Analysis of CTLA-4 and PLR in Esophageal Squamous Cell Carcinoma (ESCC) Patients.

Induction of Pyroptosis and Its Implications in Cancer Management.

The prognostic role of FZD6 in esophageal squamous cell carcinoma patients.

Nrf2 promotes esophageal squamous cell carcinoma (ESCC) resistance to radiotherapy through the CaMKIIα-associated activation of autophagy.

Concomitant Radiation Recall Dermatitis and Radiation Recall Pneumonitis Induced by Pembrolizumab.

The role of Nrf2/PIWIL2/purine metabolism axis in controlling radiation-induced lung fibrosis.

Lymphopenia in Esophageal Cancer: What Have We Learned?

The role of the deubiquitinating enzyme DUB3/USP17 in cancer: a narrative review.

A Cell Cycle Progression-Derived Gene Signature to Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma.

Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC).

CDK4/6 inhibitor enhances the radiosensitization of esophageal squamous cell carcinoma (ESCC) by activating autophagy signaling via the suppression of mTOR.

Integrated 18F-FDG PET/CT parameter defines metabolic oligometastatic non-small cell lung cancer.

Recall of reactive cutaneous capillary endothelial proliferation (RCCEP) induced by stereotactic body radiation therapy (SBRT) in a patient with lung squamous cell carcinoma.

Silencing UBQLN2 Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma (ESCC) via Activating p38 MAPK.

Prognostic factors in patients with thymoma who underwent surgery.

The role of transforming growth factor-β (TGF-β) in the formation of exhausted CD8 + T cells.